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Abstract

Key Points

IMPORTANCE Autism spectrum disorder (ASD) is highly heritable, and modest contributions of
common genetic variants to ASD have been reported. However, the association of genetic risks
derived from common risk variants with ASD traits in children from the general population is not
clear, and the association of these genetic risks with neurodevelopment in infants has not been well
understood.

Question Are genetic risks for autism
spectrum disorder (ASD) also associated
with neurodevelopment in infancy and
ASD traits among children in the general
population?
Findings In this cohort study of 734

OBJECTIVE To test whether a polygenic risk score (PRS) for ASD is associated with

infants from the Hamamatsu Birth

neurodevelopmental progress at age 18 months and ASD traits at age 6 years among children from

Cohort for Mothers and Children,

the general population.

genetic risks for ASD were associated
with ASD traits at age 6 years. The

DESIGN, SETTING, AND PARTICIPANTS In this cohort study, 876 children in the Hamamatsu Birth

polygenic risk score for ASD was

Cohort for Mothers and Children in Hamamatsu, Japan, underwent testing for the association of an

associated with delays in gross motor

ASD PRS with neurodevelopmental progress and ASD traits. Data collection began in December

and receptive language skills at age

2007 and is ongoing. Data analysis was conducted from April to December 2019.

18 months.
Meaning Genetic risks for ASD are

MAIN OUTCOMES AND MEASURES Summary data from the largest genome-wide association
study were used to generate ASD PRSs, and significance of thresholds was calculated for each
outcome. The Autism Diagnostic Observation Schedule 2 was used to measure ASD traits at age 6
years, and the Mullen Scales of Early Learning was used to measure neurodevelopmental progress at

associated with ASD traits in the general
population and neurodevelopmental
progress among infants as young as
18 months.

age 18 months.
RESULTS Of 876 participants (mean [SD] gestational age at birth, 38.9 [1.6] weeks; 438 [50.0%]
boys; 868 [99.1%] Japanese), 734 were analyzed. The ASD PRS was associated with ASD traits

Author affiliations and article information are
listed at the end of this article.

(R2 = 0.024; β, 0.71; SE, 0.24; P = .03). The association of ASD PRS with infant neurodevelopment
was most pronounced in gross motor (R2 = 0.015; β, −1.25; SE, 0.39; P = .01) and receptive language
(R2 = 0.014; β, −1.19; SE, 0.39; P = .02) scores on the Mullen Scales of Early Learning. Gene set
enrichment analyses found that several pathways, such as cell maturation (R2 = 0.057; β, −5.28; SE,
1.40; P < .001) and adenylyl cyclase activity and cyclic adenosine monophosphate concentration
(R2 = 0.064; β, −5.30; SE 1.30; P < .001), were associated with ASD traits. Gene sets associated with
inflammation were commonly enriched with ASD traits and gross motor skills (eg, chemokine motif
ligand 2 production: R2 = 0.051; β, −6.04; SE, 1.75; P = .001; regulation of monocyte differentiation:
R2 = 0.052; β, −6.63; SE, 1.90; P = .001; and B-cell differentiation: R2 = 0.051; β, 7.37; SE, 2.15;
P = .001); glutamatergic signaling–associated gene sets were commonly enriched with ASD traits and
receptive language skills (eg, regulation of glutamate secretion: R2 = 0.052; β, −5.82; SE, 1.68;
P = .001; ionotropic glutamate receptor signaling pathway: R2 = 0.047; β, 3.54; SE, 1.09; P = .001;
and negative regulation of glutamate secretion: R2 = 0.045; β, −5.38; SE, 1.74; P = .002).
(continued)
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Abstract (continued)

CONCLUSIONS AND RELEVANCE In this study, the ASD PRS was associated with ASD traits among
children from the general population. Genetic risks for ASD might be associated with delays in some
neurodevelopmental domains, such as gross motor and receptive language skills.
JAMA Network Open. 2020;3(2):e1921644. doi:10.1001/jamanetworkopen.2019.21644

Introduction
Autism spectrum disorder (ASD) is among the most common neurodevelopmental disorders. It has
been shown that genetic factors play an important role in the development of this disease, with a
high heritability of approximately 80%.1 Both rare and common variants have been considered
associated with ASD2; however, recent genome-wide association studies (GWASs) of ASD have
reported several associated genomic loci with modest contributions of common variants to ASD.3
These variants can be used to generate measures called polygenic risk scores (PRSs), which are
considered indicators of genetic liability for certain diseases or phenotypes. Although Rai et al4
demonstrated that an ASD PRS was associated with phenotypes relevant to ASD in adults from the
general population, the contribution of the ASD PRS to ASD traits in children has not been well
elucidated.
To search for early signs for ASD, previous research, including our own,5 examined possible
neurodevelopmental delays in ASD and found that some specific domains, such as language and
motor skills, were affected in individuals with ASD.6 However, the association of common genetic risk
variants for ASD with affected neurodevelopmental stagnation requires further clarification.
Moreover, although 70% of individuals with ASD do not have intellectual disability,7 the
diagnosis of ASD without intellectual disability remains a significant challenge. Recent genetic
analyses found that common risk variants for ASD are associated with high IQ,3 and individuals with
ASD and rare risk variants have high comorbidity with intellectual disability.2 Therefore, we examined
whether the PRS for ASD was associated with neurodevelopmental delays at age 18 months,
particularly in the motor and language domains, and with ASD traits at age 6 years in a populationbased birth cohort without intellectual disability. In addition, we conducted gene set enrichment
analyses to obtain biological insights into ASD traits and neurodevelopmental progress derived from
common genetic risk variants.

Methods
Participants
A total of 876 infants (438 [50.0%] boys) born between December 2007 and June 2011 in Japan
were included. Recruitment procedures are fully described elsewhere.5 The study procedures were
approved by the Hamamatsu University School of Medicine and University Hospital Ethics
Committee, and written informed consent was obtained from each mother for her infant’s
participation. This study followed the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guideline.
Overall, 66 individuals with intellectual disability (ie, full IQ <80 at age 4 years) were excluded.
An additional 8 participants with parents of non-Japanese descent were removed from the study to
minimize the potential effect of population stratification.

Measurement
The Mullen Scales of Early Learning (MSEL) was used to evaluate neurodevelopmental progress at
age 18 months. Module 3 of the Autism Diagnostic Observation Schedule 2 (ADOS-2) was used by
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certified raters to measure ASD traits at age 6 years, and the Wechsler Preschool and Primary Scale
of Intelligence, Third Edition, was used by trained psychologists to measure full IQ at age 4 years.

Genotyping, Quality Control, and Imputation
Genotyping was conducted using the Japonica array, designed for single-nucleotide polymorphism
(SNP) genotyping specific to the Japanese population.8 Briefly, the quality controls retaining SNPs
and participants were as follows: missing data for SNPs were less than 2%, pairwise identity by
descent was less than 0.2, Hardy-Weinberg equilibrium for SNPs was P > 10−6, and minor allele
frequency was greater than 0.01. A total of 76 individuals were removed from analysis because they
were shown to be related by identity-by-descent analysis. Genotyping imputation was performed
using BEAGLE 5.0 with phase 3 of the 1000 Genomes Project as a reference panel for the Japanese
population.9 We excluded SNPs with an imputation INFO score of less than 0.8. We also excluded
SNPs located within the major histocompatibility complex region because of high linkage
disequilibrium in this region. The number of SNPs analyzed for the PRS was 5 606 655.

Statistical Analysis
We generated the PRS with PRSice-2 using a recent Lundbeck Foundation Initiative for Integrative
Psychiatric Research GWAS study for ASD as a discovery cohort.3,10 The summary GWAS data for ASD
were obtained from the Psychiatric Genomics Consortium.11 To account for population stratification,
4 principle components calculated with PLINK 1.9 were used.12 The criterion for SNP clumping was a
pairwise linkage disequilibrium of R2 less than 0.1 within 1-megabase windows. We calculated PRS
scores with different P value thresholds, ranging from 5 × 10−8 to greater than .99, and best-fit PRSs
were computed with highest R2 obtained from linear regression analysis. The P values for ASD traits
and MSEL items were corrected using Bonferroni correction for 8 independent tests. Gene set
enrichment analyses and exploratory analyses for searching compounds targeting enriched gene
ontologies (GOs) were conducted using pRSet and gene2drug, respectively. Gene set collections
were obtained from the Molecular Signatures Database, and the C5 GO gene sets were used for the
analyses.13 The P values for PRSet were corrected by 10 000 permutation tests. The P values for
gene2drug were corrected using Bonferroni corrections for 1309 compounds listed in the database.
Data analysis took place from April to December 2019. Statistical significance was set at P < .05, and
all tests were 2-tailed. All analyses were conducted in PRSice-2 and PLINK 1.9.

Results
The summary of 876 participants’ characteristics is provided in Table 1. They had a mean (SD)
gestational age at birth of 38.9 (1.6) weeks, 438 (50.0%) were boys, and 868 (99.1%) were Japanese.
A total of 726 participants (373 [51.4%] boys) were analyzed.
The ASD PRS was associated with ASD traits measured by total scores on the ADOS-2
(R2 = 0.024; β, 0.71; SE, 0.25; corrected P = .03) and social affect (R2 = 0.027; β, 0.63; SE, 0.22;
corrected P = .03) but not restricted repetitive behavior (R2 = 0.023; β, 0.19; SE, 0.07; corrected
P = .06) (Table 2). The association of PRS for ASD with infant neurodevelopment was most
pronounced in gross motor skills (R2 = 0.015; β, −1.25; SE, 0.39; corrected P = .01) and receptive
language skills (R2 = 0.014; β, −1.19; SE, 0.39; corrected P = .02) measured by the MSEL (Table 2).
Gene set enrichment analyses found that several pathways, such as cell maturation
(GO:0048469; R2 = 0.057; β, −5.28; SE, 1.40; corrected P < .001), adenylyl cyclase activity and
cyclic adenosine monophosphate concentration (GO:0007193; R2 = 0.064; β, −5.30; SE, 1.30;
corrected P < .001), regulation of amino acid transport (GO:0051955; R2 = 0.052; β, −5.03; SE, 1.44;
corrected P = .001), and regulation of glutamate secretion (GO:0014048; R2 = 0.052; β, −5.82; SE,
1.68; corrected P = .001), were associated with ASD traits (Table 3). Gene set enrichment analyses
for MSEL items identified many pathways associated with ASD PRS. For example, MSEL gross motor
scores were associated with pathways associated with protein metabolism (eg, regulation of protein
JAMA Network Open. 2020;3(2):e1921644. doi:10.1001/jamanetworkopen.2019.21644 (Reprinted)
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localization: GO:0032880; R2 = 0.020; β, 6.90; SE, 1.87; corrected P < .001; negative regulation of
protein metabolic process: GO:0051248; R2 = 0.021; β, 8.82; SE, 2.37; corrected P < .001), and
receptive language scores were associated with broader pathways (eg, establishment of RNA
localization: GO:0051236; R2 = 0.022; β, −3.94; SE, 1.07; corrected P < .001; midbrain development:
GO:0030901; R2 = 0.022; β, 7.17; SE, 1.91; corrected P < .001) (Table 4).
We compared the results of gene set analyses between ASD traits and associated
neurodevelopmental domains. Among gene sets associated with ASD traits in our population, we
found that the adenylate cyclase–inhibiting G protein–coupled receptor signaling pathway

Table 1. Characteristics of 876 Participating Infants and Their Parents
Characteristic

No. (%)

Birth weight, mean (SD), g

2935.1 (444.3)

Age at birth, mean (SD)
Gestational, wk

38.9 (1.6)

Paternal, y

33.5 (5.7)

Maternal, y

29.3 (5.2)

Household income, mean (SD), millions of ¥

6.1 (2.7)

Sex
Boys

438 (50.0)

Girls

438 (50.0)

Race/ethnicity
Japanese

868 (99.1)

Mixeda
White

5 (0.5)

Latino

3 (0.3)

Size for gestational age, percentile
<10th

785 (89.6)

10th-100th

91 (10.4)

Ratio of placenta to birth weight, percentile
<10th

164 (18.7)

10th-100th

712 (81.3)

Paternal education, y
<12

65 (7.4)

≥12

811 (92.6)

Maternal education, y

a

<12

38 (4.3)

≥12

838 (95.7)

Mixed indicates that 1 parent was not of Japanese descent.

Table 2. Association of Autism Spectrum Disorder Polygenic Risk Score With Autism Spectrum Disorder Traits
P Value Threshold

SNPs, No.

R2

β (SE)

P Valuea

Social affect

.005

3492

0.027

0.63 (0.22)

.03

Restricted repetitive
behavior

.006

3002

0.023

0.19 (0.07)

.06

Total

.006

3492

0.024

0.71 (0.25)

.03

Trait
ADOS-2

MSEL
Gross motor skills

.01

4493

0.015

−1.25 (0.39)

.01

Fine motor skills

5.00 × 10−8

3

0.007

0.84 (0.38)

.22

Receptive language
development

.008

4512

0.014

−1.19 (0.39)

.02

Expressive language
development

.008

5997

0.004

−0.66 (0.37)

.59

Visual reception

.02

8144

0.004

−0.60 (0.38)

.90
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(GO:0007193) was associated with both gross motor and receptive language scores (R2 = 0.064; β,
−5.30; SE, 1.30; corrected P < .001). Other gene sets commonly associated with ASD traits and MSEL
gross motor scores included inflammation-associated gene sets, such as chemokine motif ligand 2
production (GO:0072567; R2 = 0.051; β, −6.04; SE, 1.75; corrected P = .001), regulation of monocyte
differentiation (GO:0045655; R2 = 0.052; β, −6.63; SE, 1.90; corrected P = .001), and B-cell
differentiation (GO:0030183; R2 = 0.051; β, 7.37; SE, 2.15; corrected P = .001) (Table 5). Interleukin
12 secretion (GO:0072610) was associated with ASD and gross motor skills (R2 = 0.047; β, −6.35; SE,
1.96; corrected P = .002). For receptive language scores, several gene sets associated with
glutamatergic signaling, such as regulation of glutamate secretion (GO:0014048; R2 = 0.052; β,
−5.82; SE, 1.68; corrected P = .001), ionotropic glutamate receptor signaling pathway (GO:0035235;
R2 = 0.047; β, 3.54; SE, 1.09; corrected P = .001), and negative regulation of glutamate secretion
(GO:0014050; R2 = 0.045; β, −5.38; SE, 1.74; corrected P = .002), were identified as common gene
sets associated with ASD traits and MSEL receptive language scores (Table 5).
An exploratory analysis using the 10 most significant GOs enriched in ASD traits identified
several compounds interacting with these gene sets. However, none of them remained significant
after multiple testing corrections.

Table 3. Gene Sets Enriched in Autism Spectrum Disorder Traits
Gene Set

P Value Threshold

SNPs, No.

R2

β (SE)

Cell maturation

.02

311

0.057

−5.28 (1.40)

P Valuea
<.001

Adenylate cyclase–inhibiting
G protein–coupled receptor
signaling pathway

.04

381

0.064

−5.30 (1.30)

<.001

Regulation of amino acid transport

.04

278

0.052

−5.03 (1.44)

.001

Regulation of glutamate secretion

.03

142

0.052

−5.82 (1.68)

.001

Neuron maturation

.01

165

0.052

−6.52 (1.87)

.001

Ionotropic glutamate receptor
signaling pathway

.02

335

0.047

3.54 (1.09)

.001

Locomotion

.01

3642

0.045

1.06 (0.34)

.002

Negative regulation of glutamate
secretion

.04

122

0.045

−5.38 (1.74)

.002

Regulation of cell communication by
electrical coupling involved in cardiac
conduction

.18

302

0.046

−5.26 (1.66)

.002

Negative regulation of organic acid
transport

.04

189

0.047

−5.125 (1.60)

.002

Abbreviation: SNP, single-nucleotide polymorphism.
a

P values were corrected with 10 000
permutation tests.

Table 4. Gene Sets Enriched in MSEL Gross Motor and Receptive Language Scores
SNPs, No.

β (SE)

P Valuea

Gene Set

Gross motor
skills

Neutral lipid metabolic process

.48

174

0.031

−5.09 (1.10)

<.001

Neutral lipid biosynthetic process

.07

23

0.022

−8.26 (2.14)

<.001

Regulation of protein localization

.0005

22

0.020

6.90 (1.87)

<.001

Negative regulation of protein metabolic process

.0003

17

0.021

8.82 (2.37)

<.001

Regulation of blood pressure

.006

25

0.020

−7.90 (2.18)

<.001

Negative regulation of cellular amide metabolic process

.02

39

0.020

7.21 (1.98)

<.001

Establishment of RNA localization

.22

172

0.022

−3.94 (1.07)

<.001

Nucleobase containing compound transport

.22

193

0.021

−3.71 (1.02)

<.001

Intracellular protein transport

.002

31

0.020

4.95 (1.39)

<.001

Receptive
language skills

P Value Threshold

R2

MSEL Item

Midbrain development

.26

61

0.022

7.17 (1.91)

<.001

Response to dietary excess

.31

25

0.020

−10.38 (2.94)

<.001

RNA localization

.22

188

0.020

−3.70 (1.04)

<.001

Male gamete generation

.004

24

0.018

7.42 (2.20)

<.001

Sertoli cell differentiation

.34

13

0.020

17.10 (4.82)

<.001

Abbreviations: MSEL, Mullen Scales of Early Learning; SNP, single-nucleotide
polymorphism.

a

P values were corrected with 10 000 permutation tests.
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Discussion
In this cohort study, we found that common genetic risk variants for ASD were associated with ASD
traits in Japanese children without intellectual disability from the general population. The association
of ASD PRS with ASD traits in the general population was consistent with a previous report,4 which
showed that scores of social communication and repetitive behavior were higher among individuals
with high (ie, >90th percentile) ASD PRSs. The outcomes used and the ages of participants in the
previous report were slightly different from those of our study; however, it could be fair to say that
ASD PRSs were associated with ASD traits in the general population.
We also found that these risk variants have a significant association with some domains of
neurodevelopmental progress, such as gross motor and receptive language skill development in
children from the general population without intellectual disability. Early detection and intervention
for ASD is required; however, the mean patient age at ASD detection is generally between 3 and 4
years, which may miss the opportunity for effective intervention because accelerated brain
development occurs between birth and the age of 4 years.14 Previous studies,15,16 including our own,5
have suggested that neurodevelopmental delays are relevant to ASD, and while ASD individuals
without intellectual disability do not always manifest overall neurodevelopmental delays, our
findings indicated that common genetic risks for ASD were associated with stagnation in specific
neurodevelopmental domains, such as gross motor and receptive language skills. Thus, it might be
important for clinicians and caregivers to focus on these neurodevelopmental domains to detect and
consider interventions for the future development of ASD in children without intellectual disability.
A study by Clarke et al17 found that the ASD PRS was positively associated with cognitive ability
in the general adult population, although the results were not replicated in the second cohort.
Similarly, Grove et al3 reported that higher IQ was associated with ASD PRS. These findings may seem
inconsistent with our findings; however, they could be explained by differences in the study
populations (ie, adult vs child) and the outcomes measured (ie, cognitive function vs
neurodevelopmental progress). There is a possibility that the ASD PRS was associated with
neurodevelopmental trajectory and not with final cognitive achievements. Further longitudinal
studies investigating the association of ASD PRS with cognitive development are warranted.
Several gene sets were identified as enriched in ASD traits in our population. Many of these
gene sets were associated with glutamatergic signaling and neurotransmitter signaling, which is
consistent with a previous gene set enrichment analysis of individuals with ASD.18 Excitability and

Table 5. List of Gene Sets Commonly Enriched in Autism Spectrum Disorder Traits and MSEL Items
MSEL Item

Gene Set

P Value Threshold

SNPs, No.

R2

β (SE)

P Valuea

Gross motor
skills

Adenylate cyclase–inhibiting G protein–coupled receptor
signaling pathway

.04

38

0.064

−5.30 (1.30)

<.001

Receptive
language skills

Muscle cell development

.008

44

0.052

3.91 (1.12)

<.001

Chemokine motif ligand 2 production

.14

17

0.051

−6.04 (1.75)

.001

Regulation of monocyte differentiation

.14

18

0.052

−6.63 (1.90)

.001

B-cell differentiation

.001

11

0.051

7.37 (2.15)

.001

Monocyte activation

.14

12

0.048

−6.61 (2.01)

.001

Interleukin 12 secretion

.14

13

0.047

−6.35 (1.96)

.002

Adenylate cyclase–inhibiting G protein–coupled receptor
signaling pathway

.04

38

0.064

−5.30 (1.30)

<.001

Regulation of amino acid transport

.04

27

0.052

−5.03 (1.44)

.001

Regulation of glutamate secretion

.03

14

0.052

−5.82 (1.68)

.001

Neuron maturation

.01

16

0.052

−6.52 (1.87)

.001

Ionotropic glutamate receptor signaling pathway

.02

33

0.047

3.54 (1.09)

.001

Negative regulation of glutamate secretion

.04

12

0.045

−5.38 (1.74)

.002

Abbreviations: MSEL, Mullen Scales of Early Learning; SNP, single-nucleotide
polymorphism.

a

P values were corrected with 10 000 permutation tests.
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inhibitory balance has long been implicated in the etiology of ASD,19 and it could be that this system
has also been involved in the development of ASD traits in the general population.
The adenylate cyclase–inhibiting G protein–coupled receptor signaling pathway (GO:0007193)
was strongly associated with ASD traits, gross motor skills, and receptive language progress. This
gene set includes many genes encoding neurotransmitter receptors, such as DRD2 (OMIM 126450),
DRD3 (OMIM 126451), GABBR1 (OMIM 603540), GRM2 (OMIM 604099), and HTR1A (OMIM 109760),
which are strongly implicated in various psychiatric diseases, including ASD,20 and in
neurodevelopment.21
Another important finding was that immune systems, such as regulation of monocyte
differentiation (GO:0030224) and interleukin 12 secretion (GO:0072610), might have roles in the
development of ASD traits and gross motor progress. Many studies have suggested that immune
systems are involved in the pathophysiology of ASD,22 and a 2019 cohort study23 showed that
inflammation was associated with delayed gross motor progress at age 30 months. Although it is still
unknown whether delays in gross motor progress are a direct risk of ASD or vice versa, molecules
related to immune systems, such as cytokines, might be a useful for biomarker for ASD and gross
motor progress. Given that immunomodulatory therapies have been proposed for ASD, this could
have beneficial outcomes for these phenotypes.22
Furthermore, we found that gene sets associated with glutamate signaling were closely
involved in ASD traits and receptive language skills in our study sample. Although they are still under
development, several glutamate signaling modulators have been tested for ASD24 based on the
findings from various clinical and animal studies.24,25 It has also been reported that delayed progress
in receptive language is observed in individuals with a mutation in the GRIN2A gene (OMIM 13853).26
Taken together, glutamate signaling is associated with both ASD traits and early language development.

Limitations
This study has limitations. First, we targeted a representative sample of the general population, and
thus, caution is needed when applying the findings to individuals with clinically diagnosed ASD.
Second, because there has been no large GWAS of ASD conducted using East Asian populations, we
used a study with a white population as a discovery cohort, which may partially explain the low R2 in
our PRS analyses.

Conclusions
In this study, the ASD PRS was associated with ASD traits among children in the general population.
These genetic risks were associated with specific neurodevelopmental delays. Immune systems and
glutamate signaling might be common pathways associated with ASD traits and neurodevelopmental
progress.
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